DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Piper Sandler - 2 Morgan Stanley - 2 Victoria Klesty - 1 Catalent - 1 Novo - 1 Wegovy - 1 Maggie Fick - 1 Josephine Mason - 1
Top related locs:
Oslo Norway August31 Victoria Danish Novo Denmark U.S
Top related orgs:
West Pharmaceutical Services - 4 Bank of America - 2 Technologies - 2 Nvidia - 2 REUTERS - 1 Novo Nordisk - 1 U.S - 1 Novo - 1

Search resuls for: "West Pharmaceutical Services"


8 mentions found


☆ How Novo Nordisk makes its weight-loss drug Wegovy
  + stars: | 2023-11-01 | by ( Maggie Fick | ) www.reuters.com   time to read: +3 min
[1/2] A 0.25 mg injection pen of Novo Nordisk's weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, August31, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Acquire Licensing RightsLONDON, Nov 1 (Reuters) - Novo Nordisk (NOVOb.CO) is spending billions of dollars to boost output and ease shortages of its hugely popular, highly effective weight-loss medicine Wegovy. FILL-FINISHNovo has hired Catalent (CTLT.N), a large U.S. contract drug manufacturer, to fill injection pens for Wegovy at two of that company's plants: in Brussels and in Bloomington, Indiana. Novo has also hired another U.S. firm, Thermo Fisher (TMO.N), as a Wegovy pen filler. COMPONENTSThe Wegovy injection pens for the U.S. market slightly differ from those sold in the European markets including Norway, Denmark, Germany and UK, where it has so far launched.
Persons: Victoria Klesty, Catalent, Novo, Wegovy, Maggie Fick, Josephine Mason, Tomasz Janowski Organizations: REUTERS, Novo Nordisk, U.S, Novo, Reuters, PCI Pharma Services, autoinjectors, West Pharmaceutical Services, Stevenato, SCHOTT Pharma, Thomson Locations: Oslo, Norway, August31, Victoria, Danish, Novo, Denmark, U.S, Brussels, Bloomington , Indiana, Greenville , North Carolina, Greenville, Germany, Europe, Swiss
☆ Hedge fund run by T. Rowe Price's former star manager adds to bets in health care, industrials
  + stars: | 2023-08-17 | by ( Jesse Pound | In Jesse-Pound | ) www.cnbc.com   time to read: +2 min
A fast-growing hedge fund tacked toward health care and industrial stocks during the second quarter, according to securities filings released this week. Durable Capital Partners is a relatively new firm by Henry Ellenbogen, who helmed T. Rowe Price's New Horizons fund for most of the last decade. In the second quarter, the fund added to several health care and industrial stocks, according to security filings and data compiled by Verity's InsiderScore. On the industrials side, Durable increased its stakes in JB Hunt Transportation and RBC Bearings by 27.3% and 10.2%, respectively, according to Verity and securities filings. Since the second quarter ended on June 30, Durable Capital has disclosed three more groups of transactions.
Persons: Henry Ellenbogen, Rowe, Morningstar, Ellenbogen, Verity's, Verity Organizations: Partners, West Pharmaceutical Services, Molina Healthcare, Privia, JB, Transportation, RBC, Intuit, FirstService Corp, SS, C Technologies Locations: West, MSCI, Duolingo
☆ Stocks making the biggest moves midday: Virgin Galactic, iRobot, Cava, SoFi and more
  + stars: | 2023-06-16 | by ( Sarah Min | ) www.cnbc.com   time to read: +3 min
iRobot — The stock surged 19% after U.K. regulators approved Amazon's $1.7 billion acquisition of the Roomba vacuum cleaner maker. Cava Group — Cava Group shares dropped 15% during trading Friday, giving back some of its gains from its massive debut Thursday on the New York Stock Exchange. SoFi Technologies — The financial technology stock dropped more than 8% after both Bank of America and Piper Sandler downgraded it to neutral from buy, citing SoFi's recent run higher. Micron Technology — Shares dipped 1.5% after Micron Technology said a China chip ban could hurt the company. Truist Financial — Shares fell 1.6% after Odeon Capital Group downgraded Truist Financial to hold from buy, according to FactSet.
Persons: Richard Branson, iRobot, Piper Sandler, Refinitiv, Morgan Stanley, Joseph Moore, — CNBC's Michelle Fox, Alex Harring, Yun Li Organizations: Virgin Galactic —, West Pharmaceutical Services, Bank of America, — Cava, New York Stock Exchange, Technologies, Adobe, Nvidia, Devices, Micron Technology, U.S . Securities, Exchange Commission, — Humana, Odeon Capital Locations: China
☆ Here are Friday's biggest analyst calls: SoFi Technologies, AutoZone, Nvidia, Meta and more
  + stars: | 2023-06-16 | by ( Sarah Min | ) www.cnbc.com   time to read: +6 min
Bank of America downgrades SoFi Technologies to neutral from buy The downgrade follows SoFi' s recent rally. Our C$51 Price Target is 39% above the current stock price and we see close to 3:1 upside/downside skew." UBS upgrades AutoZone to buy from neutral Analyst Michael Lasser raised the price target to $2,900 from $2,800. Wells Fargo initiates Neogen Corporation at overweight and $22 price target Wells Fargo said it liked the company's improving margins. Wells Fargo initiates Bio-Rad Laboratories Inc. at overweight and $550 price target Wells said Bio-Rad's valuation is attractive at current levels.
Persons: Jefferies, John Hecht, LendingClub, Morgan Stanley, Mauricio Serna, Aritzia, Michael Lasser, Carvana, it's, Wells, Ph3, Wells Fargo, Piper Sandler, TD Cowen downgrades, LOE, Michael Bloom Organizations: . Bank of America, Technologies, Nvidia, Bank of America, UBS, West Pharmaceutical Services, Stevanato, MorphoSys, Neogen, Rad Laboratories Inc, SoFi Technologies, Health Companies Locations: EBITDA, 4Q23, BLCO
☆ These S&P 500 stocks crushed it in the first quarter. Here's where analysts see them going
  + stars: | 2023-04-02 | by ( Fred Imbert | ) www.cnbc.com   time to read: +4 min
The S & P 500 just wrapped up a wild first quarter with surprisingly strong results. The tech and communication services sectors powered the S & P 500 higher, rising more than 20% each. Here are the 10 best S & P 500 stocks for the first quarter, and where analysts see them going based on the implied upside (or downside) to their average price targets. Nvidia led the way higher among S & P 500 stocks, surging 90.1%. As for Catalent, analysts see the stock rallying 24.5% after surging 46% in the first quarter.
☆ This week's best performers include Paramount Global and a little-known pharma stock
  + stars: | 2023-02-17 | by ( Fred Imbert | ) www.cnbc.com   time to read: +2 min
The average price target on West Pharmaceuticals implies downside of 7.2% over the next 12 months, and only one-third of analysts rate the stock as buy. Paramount Global also popped this week, gaining around 9% after the media giant said it would increase subscription prices for its Paramount+ streaming service . Just 21% rate it as buy, and the average price target implies downside of 13%. Three-quarters of analysts covering the pet medication maker rate it as buy, with the average analyst price target implying upside of 25.3%. Canaccord Genuity upgraded the stock on the back of those results, noting it has 30% upside from here.
☆ Stocks making the biggest moves midday: Twilio, Tripadvisor, Boston Beer, Roku and more
  + stars: | 2023-02-16 | by ( Sarah Min | ) www.cnbc.com   time to read: +3 min
Twilio — Shares jumped 19% after Twilio beat revenue expectations in its most recent quarter. Otherwise, Shopify beat expectations on the top and bottom lines. The digital communications stock reported earnings of 88 cents per share on revenue of $13.59 billion. Hasbro — Hasbro rose more than 2% after the toymaker beat earnings per share expectations. Otherwise, the firm beat earnings expectations in its latest quarter, while revenue came in line with estimates.
☆ Stocks making the biggest premarket moves: Shake Shack, Virgin Galactic, Paramount and more
  + stars: | 2023-02-16 | by ( Michelle Fox | ) www.cnbc.com   time to read: +4 min
Analysts surveyed by Refinitiv were expecting earnings of 23 cents per share on $8.16 billion of revenue. Excluding items, it earned 88 cents per share, slightly above the Refinitiv estimate of 86 cents per share. Cisco also beat revenue expectations. Twilio — The communications tools maker rose nearly 9% after reporting revenue of $1.02 billion, above the $1 billion analyst polled by Refinitiv expected. West Pharmaceutical Services — The drug and health-care products manufacturer gained 5.3% after reporting a fourth-quarter earnings and revenue beat.
0 next >>
Total: 8